Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes.

Keepers GA, Clappison VJ, Casey DE.

Arch Gen Psychiatry. 1983 Oct;40(10):1113-7.

PMID:
6138011
2.

Treatment of acute neuroleptic-induced movement disorders.

Tonda ME, Guthrie SK.

Pharmacotherapy. 1994 Sep-Oct;14(5):543-60. Review.

3.

Prevalence of tardive dyskinesia.

Tepper SJ, Haas JF.

J Clin Psychiatry. 1979 Dec;40(12):508-16. Review.

PMID:
40964
4.

Movement disorders associated with neuroleptic treatment.

Wirshing WC.

J Clin Psychiatry. 2001;62 Suppl 21:15-8. Review.

5.

Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.

Casey DE.

Psychiatr Clin North Am. 1993 Sep;16(3):589-610. Review.

PMID:
8105453
6.

What can we do about acute extrapyramidal symptoms?

Gray R, Gournay K.

J Psychiatr Ment Health Nurs. 2000 Jun;7(3):205-11. Review.

PMID:
11249313
7.

EPS profiles: the atypical antipsychotics are not all the same.

Weiden PJ.

J Psychiatr Pract. 2007 Jan;13(1):13-24. Review.

PMID:
17242588
8.

Clinical management of acute neuroleptic-induced extrapyramidal syndromes.

Keepers GA, Casey DE.

Curr Psychiatr Ther. 1986;23:139-57. Review. No abstract available.

PMID:
2870879
9.

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Caligiuri MR, Jeste DV, Lacro JP.

Drugs Aging. 2000 Nov;17(5):363-84. Review.

PMID:
11190417
10.

Tardive drug-induced extrapyramidal syndromes.

Marsálek M.

Pharmacopsychiatry. 2000 Sep;33 Suppl 1:14-33. Review.

PMID:
11072762
11.

Motor and mental aspects of acute extrapyramidal syndromes.

Casey DE.

Acta Psychiatr Scand Suppl. 1994;380:14-20. Review.

PMID:
7914042
12.

Neuromotor dysfunction in early psychosis.

Whitehorn D, Kopala LC.

Ann Clin Psychiatry. 2002 Jun;14(2):113-21. Review.

PMID:
12238736
13.

Clozapine withdrawal-emergent dystonias and dyskinesias: a case series.

Ahmed S, Chengappa KN, Naidu VR, Baker RW, Parepally H, Schooler NR.

J Clin Psychiatry. 1998 Sep;59(9):472-7. Review.

PMID:
9771818
14.

Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia.

Arana GW, Goff DC, Baldessarini RJ, Keepers GA.

Am J Psychiatry. 1988 Aug;145(8):993-6. Review.

PMID:
2899403
15.

[Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].

van Berkel M, Bogers JP, Bouvy PF.

Tijdschr Psychiatr. 2007;49(1):37-41. Review. Dutch.

16.

Effects of newer antipsychotics on extrapyramidal function.

Tarsy D, Baldessarini RJ, Tarazi FI.

CNS Drugs. 2002;16(1):23-45. Review. Erratum in: CNS Drugs. 2003;17(3):202.

PMID:
11772117
17.

Focus on lower risk of tardive dyskinesia with atypical antipsychotics.

Nasrallah HA.

Ann Clin Psychiatry. 2006 Jan-Mar;18(1):57-62. Review.

PMID:
16517454
18.

Movement disorders with neuroleptic drug treatment.

Tarsy D.

Psychiatr Clin North Am. 1984 Sep;7(3):453-71. Review.

PMID:
6148742
19.

A systematic approach to pharmacotherapy in patients with neuroleptic-resistant psychoses.

Osser DN.

Hosp Community Psychiatry. 1989 Sep;40(9):921-7. Review.

PMID:
2571557
20.

Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.

Andrew HG.

Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S76-80. Review.

PMID:
7874668

Supplemental Content

Support Center